[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Jacob Plieth posts on X about $bmy, pfe, $pfe, $gild the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Social category influence stocks XXXX% currencies #1146 cryptocurrencies XXXX% finance XXXX% countries XXXX%
Social topic influence $bmy 3.29%, pfe 2.88%, $pfe 2.88%, $gild #2, $gsk 2.06%, $onc 1.65%, $azn #4, jnj 1.65%, $jnj 1.65%, $legn XXXX%
Top accounts mentioned or mentioned by @apexonco @evaluatevantage @applehelix @bertrandbio @ej23ny @bymadeleinea @drpaulydesantis @avidresearch @evaluatepharma @vantageanalysis @mykalt45 @adamfeuerstein @byjofagg @adar170 @raffcolo @gatoncarlos @stevedoc22 @ablt315i @persimmonti @maverickny
Top assets mentioned Bristol-Myers Squibb Co (BMY) Pfizer, Inc. (PFE) Gilead Sciences, Inc. (GILD) GSK plc (GSK) One Cash (ONC) AstraZeneca PLC (AZN) Johnson & Johnson (JNJ) Merck & Co., Inc. (MRK) Seagen Inc (SGEN) Immunogen Inc (IMGN) Arvinas, Inc (ARVN) Revolution Medicines, Inc. Common Stock (RVMD) Synthetify (SNY) Blueprint Medicines Corporation (BPMC) Eli Lilly and Company (LLY) IDEAYA Biosciences, Inc. Common Stock (IDYA) Novartis AG (NVS) Regeneron Pharmaceuticals Inc (REGN)
Top posts by engagements in the last XX hours
"Radiance Biopharma has links to $SGEN and last year licensed Biocytogen's anti-HER2 x TROP2 bispecific ADC YH012/RB-201. Now it's the latest to get into ROR1 $IPN.PA $STRO $ZLAB $ZNTL $IMNM" @JacobPlieth on X 2025-02-19 09:50:39 UTC 29.9K followers, 3511 engagements
"My earlier story on the resurrection of folate receptor $STRO $BMY $ESALY $MRKR $IMGN $ECYT" @JacobPlieth on X 2021-06-18 06:30:45 UTC 29.9K followers, XX engagements
"$ONC $BGNE confirmed to us that it's working both on a Ras(on) inhibitor and on developing ADCs that use this Ras(on) inhibitor as a "non-cytotoxic payload"" @JacobPlieth on X 2025-06-30 14:56:42 UTC 29.9K followers, 2140 engagements
"Here we go: $PFE just went into ph3 with Kat6 $OLMA" @JacobPlieth on X 2025-07-16 11:27:35 UTC 29.9K followers, 3284 engagements
"5000 patients later $RHHBY finally dumps its #tigit (Sky-14 is quietly said to have failed). Via @ApexOnco - $RCUS $GILD $AZN" @JacobPlieth on X 2025-07-24 11:34:06 UTC 29.9K followers, 8864 engagements
"Nerd alert What do the latest proposed INNs tell us about $MGNX $AZN $BNTX $GSK $IVBXF and other ADCs Via @ApexOnco - H/t @raffcolo" @JacobPlieth on X 2025-07-21 08:38:24 UTC 29.9K followers, 3524 engagements
"PD-1 x VEGF is all very well but how about PD-1 x Lag-3 3SBio reckons it's worth taking into the clinic $PFE $BMY" @JacobPlieth on X 2025-06-16 08:15:44 UTC 29.9K followers, 5821 engagements
"@AppleHelix Given what $MRK stands to pay under the PD-1 x VEGF deal even considering the payaway did she/Lanova sell out too cheaply to Sino" @JacobPlieth on X 2025-07-18 13:36:03 UTC 29.9K followers, XXX engagements
"Nanjing Leads IPO document reveals that $ONC terminated its Lag3 deal in May. Should start trading tomorrow. Via @ApexOnco -" @JacobPlieth on X 2025-07-24 13:34:30 UTC 29.9K followers, 2115 engagements
"You already have a small-molecule inhibitor so do you also need a degrader $ONC $BGNE thinks yes for BTK CDK2 & Kras. Via @ApexOnco - $ARVN $GILD $RVMD" @JacobPlieth on X 2025-06-30 14:45:43 UTC 29.9K followers, 4537 engagements
"Admirable effort by FDA's Deepti Telajara to present the current treatment paradigm for multiple myeloma $JNJ $BMY $GSK" @JacobPlieth on X 2025-07-17 12:18:51 UTC 29.9K followers, 9365 engagements
"$COGT +25% as bezuclastinib safety remains in the spotlight. Via @ApexOnco - $BPMC $SNY" @JacobPlieth on X 2025-07-07 18:07:11 UTC 29.9K followers, 6627 engagements
"#Varda $187m raise to manufacture "drugs in space" got lots of traction yesterday so I guess people think use of microgravity is pretty novel. But apparently $LLY was doing this already in. 2016 h/t @raffcolo" @JacobPlieth on X 2025-07-11 11:43:00 UTC 29.9K followers, 2865 engagements
"KAT6 which recently saw the entry of $IDYA could soon see $OLMA start ph1 and $PFE enter ph3. But how combinable are these molecules given the tox Via @ApexOnco -" @JacobPlieth on X 2025-01-06 15:06:43 UTC 29.9K followers, 6760 engagements
"@avidresearch .and is still being wasted $AZN $RCUS $GILD" @JacobPlieth on X 2025-07-24 11:41:33 UTC 29.9K followers, XXX engagements
"What in the wide wide world of sports $SONN" @JacobPlieth on X 2025-07-14 10:40:47 UTC 29.9K followers, 8822 engagements
"@MaverickNY @chuminhua432 @jbdotdotdot Also the clue is in the ct-gov exclusion criteria" @JacobPlieth on X 2025-07-04 09:23:36 UTC 29.9K followers, 3091 engagements
"Fascinating Evercore ISI webinar going on right now about disconnect between value of Sino deal and what $MRK owes Lanova on the PD-1 x VEGF. In summary: XX% of $588m MRK up front and XX% of the $300m tech transfer actually went to Genscript () $LEGN" @JacobPlieth on X 2025-07-18 13:23:35 UTC 29.9K followers, 11K engagements
"Quite the tangled web: Dualitybio's Her2 ADC trastuzumab pamirtecan is licensed to $BNTX (of $BMY PD-L1 x VEGF fame) ex-China and to 3SBio (of $PFE PD-1 x VEGF fame) in China" @JacobPlieth on X 2025-06-06 08:53:59 UTC 29.9K followers, 4862 engagements
"FWIW the CRLs in FDA's newly released list concerning oncology drugs (excl generics) are for: - penpulimab - torpialimab $CHRS - Fotivda - Trodelvy $GILD - Vyloy $ALPMF" @JacobPlieth on X 2025-07-10 15:50:43 UTC 29.9K followers, 5925 engagements
"According to the sellside 177Lu-PSMA-617 is $NVS's most valuable pipeline asset. Let that sink in for a moment" @JacobPlieth on X 2021-03-23 09:10:07 UTC 29.9K followers, XX engagements
"Is anyone able to translate this into English TIA $SONN" @JacobPlieth on X 2025-07-14 13:36:13 UTC 29.9K followers, 4921 engagements
"So judging by panellists' comments the key issue was $GSK's refusal to investigate lower Blenrep doses. Pertinent slide from FDA:" @JacobPlieth on X 2025-07-17 16:51:27 UTC 29.9K followers, 3939 engagements
"Support for $PFE mevrometostat's ph3 plan but comparison vs $IPN.PA Tazverik Cello-1 readout doesn't add up. Via @ApexOnco at #GU25 - $ORIC" @JacobPlieth on X 2025-02-13 15:04:55 UTC 29.9K followers, 12.9K engagements
"I scoured the FDA's cache of CRLs and found six that relate to novel oncology drugs. Includes first formal disclosure that Akeso's penpulimab got a CRL in 2024. Via @ApexOnco - $AVEO $IMMU $GILD $CHRS $ALPMF $CKPT" @JacobPlieth on X 2025-07-11 12:30:59 UTC 29.9K followers, 5803 engagements
"Guess who's about to take a SC anti-PD-1 into phase X Via @ApexOnco - $ONC $BGNE $RHHBY $AZN $MRK $BMY $PFE" @JacobPlieth on X 2025-07-04 10:11:15 UTC 29.9K followers, 4213 engagements
"$GMAB quietly discontinued the mystery oncology project GEN1078 months after it first went into phase X. Likely T-cell engager via Omniab; any idea as to target(s) Via @ByMadeleineA -" @JacobPlieth on X 2025-07-09 15:51:00 UTC 29.9K followers, 3312 engagements
".and already my head hurts (slide from $GSK)" @JacobPlieth on X 2025-07-17 12:57:38 UTC 29.9K followers, 1918 engagements
"$GSK Blenrep should return to the US #ASCO24 hears. Via @ApexOnco - $JNJ $BMY $PFE $TSVT $LEGN $REGN" @JacobPlieth on X 2024-06-02 12:37:07 UTC 29.9K followers, 14.1K engagements
"Most remarkable thing about this deal is that $AVEO is worth more than $ATNM (by $5m)" @JacobPlieth on X 2022-02-22 13:41:09 UTC 29.9K followers, XX engagements
"Another bombshell via Evercore: founder of Lanova is married to the founder of $IMAB (did I hear that right)" @JacobPlieth on X 2025-07-18 13:34:34 UTC 29.9K followers, 3136 engagements
".and more this time from the FDA's Andrea Baines $BMY $JNJ $GSK $LEGN" @JacobPlieth on X 2025-07-17 13:22:57 UTC 29.9K followers, 2746 engagements